Continuing Medical Education Questions: June 2022 Asombang, Akwi W. MD, MPH, FACG
Massachusetts General Hospital, Boston, Massachusetts
doi: 10.14309/ajg.0000000000001808
Abstract
Article Title: Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on Colorectal Cancer
LEARNING OBJECTIVE
Explain preventive medicine tools for patients with gastrointestinal hamartomatous polyposis syndromes at increased risk for gastrointestinal cancers
QUESTION 1
A 20-year-old man presents for screening colonoscopy due to a family history of colorectal cancer in his mother at age 30 years. The colonoscopy reveals multiple polyps with pathology confirming 4 of the 6 are hamartomatous polyps less than 1 cm. What is the next step in management for this patient?
CT abdomen/pelvis with contrast
CEA now and at 6 months
Genetic testing
Repeat colonoscopy at 5 years
QUESTION 2
A 45- year-old patient undergoes colonoscopy with polypectomy of an 8 mm polyp. Pathology is reported as “characteristic hypercellularity with glandular crowding, enlarged nuclei, increased mitotic activity and reduced goblet cells” (Figure 1). What is the most likely diagnosis?
Peutz-Jeghers polyp
Juvenile polyp
Ganglioneuroma
Adenomatous polyp
Figure 1.: Cumulative incidence plot for esophageal second primary tumors with death as competing risk in patients with head and neck squamous cell carcinoma. CI, confidence interval.
QUESTION 3
A 42-year-old patient with a history of Peutz-Jeghers Syndrome (PJS) and gastroesophageal reflux disease presents to a clinic for follow-up of results from a recent upper endoscopy and colonoscopy. Clinically, the patient denies abdominal pain, nausea or vomiting. The patient is currently taking omeprazole 20 mg twice daily. On physical examination, vitals are stable. Fasting comprehensive metabolic panel and complete blood count are normal. What additional diagnostic study should be performed?
Fasting glucose
No further studies at this time: return to clinic at 1 year
Magnetic resonance cholangiopancreatography (MRCP)
CT abdomen with contrast
© 2022 by The American College of Gastroenterology View full article text